Independent Medical Education Grants

Transcription

1 1 st Jul th Sep 015 Sanofi US and its affiliate Genzyme Corporation are committed to supporting independent medical education activities in therapeutic areas in which the Company is involved, for healthcare professionals, patients, and consumers to improve patient care and health outcomes in therapeutic areas in which the Company is engaged. Sanofi US and Genzyme Corporation are part of the Sanofi Group, a global pharmaceutical company. Amount Academic CME, LLC APPLYING ADVANCED TREATMENT STRATEGIES WITHIN RHEUMATOID ARTHRITIS 6,40 AKH Inc. Advancing Knowledge and Healthcare Florida Society of Rheumatology FLORIDA SOCIETY OF RHEUMATOLOGY 015 ANNUAL CME CONFERENCE 5,000 American Academy of Continuing Medical Education, Inc. TRANSLATING CLINICAL DATA INTO NEPHROLOGY PRACTICE IN THE MANAGEMENT OF HYPERPHOSPHATEMIA 149,800 American Association of Clinical Endocrinologists HEARTLAND-AACE 6TH ANNUAL MEETING 7,500 American Association of Clinical Endocrinologists ILLINOIS CHAPTER OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS 5TH ANNUAL METING 5,000 American Association of Diabetes Educators Horizon CME, Inc. INHALED INSULIN A BREATH OF FRESH AIR FOR THE TREATMENT OF DIABETES 6,800 American Diabetes Association 0TH ANNUAL CLINICAL CONFERENCE ON DIABETES: BEYOND THE NUMBERS 5,000 American Diabetes Association DIABETES AND ENDOCRINE DISORDERS FOR THE GENERALIST AND SPECIALIST 5,000 American Diabetes Association TRANSITIONS OF CARE THROUGH THE DIABETES LIFESPAN 5,000 American Society of Nephrology ASN BOARD REVIEW COURSE AND UPDATE 15,000 American Society of Nephrology CALCIUM OR NO CALCIUM: THAT IS THE QUESTION 15,85 Amount is the amount that the Company funded during Q, 015 identified above based upon an agreement. Recipients are

2 1 st Jul th Sep 015 Amount American Urological Association Education & Research, Inc. ESTABLISHING AN ADVANCED PROSTATE CANCER CLINIC: A PRACTICAL GUIDE FOR THE UROLOGY CLINIC 60,000 Association of Family Practice Physician Assistants JOINT ASPIRATION/INJECTION WORKSHOP 5,00 Cardiovascular Society of Buffalo and Western NY SUNY AT BUFFALO CME OFFICE UNDERSTANDIJG FABRY DISEASE FROM A CARDIAC PERSPECTIVE 7,000 Cleveland Clinic Educational Foundation CURRENT AND FUTURE THERAPEUTIC OPTIONS TARGETING RESIDUAL CVD RISK: EMERGING THERAPIES FOR THE TREATMENT OF DYSLIPIDEMIA 80,000 CME Outfitters, LLC RISKY BUSINESS: UNDERSTANDING AND ATTENUATING RISK ASSOCIATED WITH DISEASE-MODIFYING THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS 07,090 Consortium of Multiple Sclerosis Centers Nurse Practitioner Alternatives EXPERT DEBATES IN MULTIPLE SCLEROSIS: OPPOSING VIEWS IN MANAGEMENT 15,000 Consortium of Multiple Sclerosis Centers Nurse Practitioner Alternatives PATIENTGPS?: CLINICAL PATHS TO EXPLORE TREATMENT OPTIONS AND INDIVIDUALIZE THERAPY IN MULTIPLE SCLEROSIS 100,000 Dignity Health MandatoryCE LLC ND ANNUAL NEW MEXICO REGIONAL DIABETES SYMPOSIUM 45,000 FORE 015 ORTHOPAEDICS FOR THE PRIMARY CARE PRACTITIONER & REHABILITATION THERAPIST 4,000 Humboldt-Del Norte Consortium for Continuing Medical Education MULTIPLE SCLEROSIS 4,100 Icahn School of Medicine at Mount Sinai MULTIPLE SCLEROSIS AND ITS MIMICS 1,90 Icahn School of Medicine at Mount Sinai ADVANCES IN PEDIATRIC FOOD ALLERGY 15,000 Institute for the Advancement of Human Behavior Answers in CME, Inc. LEARNER-DIRECTED CME: WHAT DO PRIMARY CARE PROVIDERS NEED TO KNOW ABOUT THE LATEST ADVANCES IN THE TREATMENT HYPERCHOLESTEROLEMIA 49,500 Amount is the amount that the Company funded during Q, 015 identified above based upon an agreement. Recipients are

3 Johns Hopkins University Advanced Studies in Medicine Johns Hopkins University Advanced Studies in Medicine 1 st Jul th Sep 015 Amount THE 11TH ANNUAL JOHNS HOPKINS MULTIPLE SCLEROSIS SYMPOSIUM SERIES 10,000 COMPREHENSIVE CARE FOR PATIENTS WITH GAUCHER DISEASE: EMERGING CONCEPTS FOR IMPROVED OUTCOMES 195,100 MANAGEMENT OF PERSISTENT HYPERGLYCEMIA IN TYPE DIABETES: BEYOND Johns Hopkins University STARTING DOSES OF BASAL INSULIN Medical Logix, LLC 81,750 Medical Education Resources Tarsus Cardio Inc. dba Health Science Media THE EVOLUTION OF INSULIN THERAPY: NEW DEVELOPMENTS IN TREATMENT, TECHNOLOGY, AND METHODS OF ADMINISTRATION 100,000 Medical Learning Institute, Inc. PeerView Institute for Medical Education, Inc. PEERVIEW INREVIEW, RISING TO THE CHALLENGE: FOSTERING EFFECTIVE PATIENT- PROVIDER COMMUNICATION THROUGHOUT THE COURSE OF POMPE DISEASE 100,000 Medical University of South Carolina 1ST ANNUAL NEPHROLOGY TRANSPLANT SYMPOSIUM FOR NEPHROLOGISTS, PRIMARY CARE AND HOSPITALISTS,500 Med-IQ, LLC TARGETING MODERATE-TO-SEVERE ATOPIC DERMATITIS: EVOLVING TREATMENT STRATEGIES TO ADDRESS A KEY UNMET MEDICAL NEED 99,896 Med-IQ, LLC CASE SIMULATIONS IN TUMOR LYSIS SYNDROME: AGGRESSIVE PROPHYLAXIS STRATEGIES TO PREVENT ADVERSE PATIENT OUTCOMES 100,000 Med-IQ, LLC UPDATE FOR CLINICIANS: THE POTENTIAL OF IL-6 INHIBITORS TO REVOLUTIONIZE RHEUMATOID ARTHRITIS TREATMENT 104,578 Medscape, LLC A PRACTICAL GUIDE TO THE PREVENTION OF SURGICAL ADHESIONS 160,000 Medscape, LLC IDENTIFYING AND ADDRESSING INADEQUATELY MANAGED OSTEOARTHRITIS PAIN 18,500 Medscape, LLC GLP-1 RECEPTOR AGONISTS IN TD MANAGEMENT: THE MODERN INJECTABLE 105,100 Missouri Academy of Physician Assistants THE GOOD, THE BAD, AND THE IATROGENIC?,500 Amount is the amount that the Company funded during Q, 015 identified above based upon an agreement. Recipients are

4 1 st Jul th Sep 015 Amount Missouri Academy of Physician Assistants JOINT INJECTIONS 5,000 Montefiore Medical Center PlatformQ Health Education, LLC A COMPREHENSIVE PERSPECTIVE ON INSULIN REPLACEMENT FOR TYPE DIABETES 100,000 Montefiore Medical Center PlatformQ Health Education, LLC MULTIPLE SCLEROSIS: EXPLORING TREATMENT OPTIONS AND INDIVIDUALIZING THERAPY 85,000 National Association of Managed Care Physicians, Inc. ADVANCES IN THE MANAGEMENT OF MULTIPLE SCLEROSIS: A CLOSER LOOK AT NOVEL THERAPIES 57,000 National Association of Managed Care Physicians, Inc. INDIVIDUALIZING TREATMENT STRATEGIES FOR EFFECTIVE A1C REDUCTION AND IMPROVED OUTCOMES IN TYPE DIABETES 57,000 National Jewish Health California Society of Allergy, Asthma and Immunology CSAAI RD ANNUAL EDUCATIONAL MEETING 10,000 National Kidney Foundation, Inc. GREENSBORO PATIENT EMPOWERMENT WORKSHOP,500 CHRONIC KIDNEY DISEASE & THE PRIMARY CARE PRACTITIONER: EARLY SCREENING AND PREVENTION FOR THE AT-RISK PATIENT National Kidney Foundation, Inc. 5,000 11TH ANNUAL JOINT MEETING OF THE UPSTATE AND WESTERN NEW YORK National Kidney Foundation, Inc. COUNCILS ON RENAL NUTRITION 5,000 NEW TYPE DIABETES GUIDELINES AND THE TREND TOWARD NEWER PHARMACOLOGICAL TREATMENT 100,000 National Medical Association North American Center for Continuing Medical Education, LLC Horizon CME, Inc. IMPLEMENTING BEST PRACTICES FOR TUMOR LYSIS SYNDROME 100,000 Not-For-Profit Hospital Corporation CHRONIC KIDNEY DISEASE: STATE OF THE ART 015 1,900 Pennsylvania Academy of Family Physicians Foundation PA ACADEMY OF FAMILY PHYSICIANS FOUNDATION A1C CHALLENGE 150,000 Amount is the amount that the Company funded during Q, 015 identified above based upon an agreement. Recipients are

5 1 st Jul th Sep 015 Amount Pennsylvania Society of Physician Assistants THYROID MASSES 8,400 Pharmacy Times Office of Continuing Professional Education CONVENIENT CARE OPPORTUNITIES TO OPTIMIZING INSULIN THERAPY IN TREATMENT OF TYPE DIABETES 48,689 Pharmacy Times Office of Continuing Professional Education PQA, Inc. AJPB QUALITY FORUM: IMPLEMENTATION OF QUALITY MEASURES TO IMPROVE OUTCOMES IN DYSLIPIDEMIA 50,000 Pharmacy Times Office of Continuing Professional Education PQA, Inc. AJPB QUALITY FORUM: AIMING FOR A FIVE-STAR RATING IN DIABETES CARE: MANAGED CARE PLANS AND COMMUNITY PHARMACIST COLLABORATION 50,000 Postgraduate Healthcare Education, LLC Medical Logix, LLC ADDRESSING HYPOGLYCEMIA IN TYPE DIABETES MELLITUS: THE PHARMACISTS ROLE IN OPTIMIZING PATIENT OUTCOMES 0,000 Postgraduate Institute for Medicine C-MEducation Resources, LLC NOVEL MECHANISMS AND ADVANCING THERAPEUTIC PARADIGMS FOR OPTIMIZING LDL-FOCUSED MANAGEMENT AND CARDIOPROTECTION IN THE DIABETIC PATIENT 79,000 Postgraduate Institute for Medicine C-MEducation Resources, LLC THE IQ&A INTERACTIVE CARDIOVASCULAR INTELLIGENCE ZONE: NEW FRONTIERS IN LDL-TARGETED CV RISK REDUCTION Amount is the amount that the Company funded during Q, 015 identified above based upon an agreement. Recipients are 8,100 Preventive Cardiovascular Nurses Association 015 FALL LEARNING SERIES 5,000 PRIME Education Inc. (PRIME) CASE-BASED DEBATES ABOUT UTILITY OF PCSK9 INHIBITORS IN PATIENT POPULATIONS FOR LIPID REDUCTION 1,000 PRIME Education Inc. (PRIME) INTERNATIONAL INSIGHTS ON TREATMENT ADVANCES FOR RHEUMATOID ARTHRITIS 166,077 PRIME Education Inc. (PRIME) NEW CHALLENGES IN THE PREVENTION AND MANAGEMENT OF TUMOR LYSIS SYNDROME IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA 78,810 Pri-Med Institute, LLC (d/b/a pmicme) Horizon CME, Inc. DYSLIPIDEMIA IN PRIMARY CARE: NEW GUIDELINE RECOMMENDATIONS AND TREATMENT OPTIONS 50,000 ProCE, Inc. Institute for Safe Medication Practices CONCENTRATED INSULIN: SAFE USE IN THE HOSPITAL AND TRANSITIONS OF CARE 10,

6 1 st Jul th Sep 015 Amount Projects In Knowledge, Inc. MULTIPLE POINT OF CARE 00,000 Regents of the University of Colorado RENAL DISEASE & ELECTROLYTE DISORDERS COURSE,000 Regents of the University of Colorado American Thyroid Association PEDIATRIC AND ADULT DIFFERENTIATED THYROID CANCER, ARE THEY DIFFERENT? 75,000 Regents, University of California THIRD ANNUAL UCLA REVIEW OF CLINICAL NEUROLOGY 15,000 Rush University Medical Center DEVELOPING AN INTEGRATIVE APPROACH TO METASTATIC PROSTATE CANCER: MAKING IT PERSONAL TO IMPROVE CLINICAL OUTCOMES Plexus Communications 65,000 Rutgers, The State University of New Jersey Global Academy for Medical Education, LLC 8TH ANNUAL PERSPECTIVES IN RHEUMATIC DISEASES, PRESENTED BY RHEUMATOLOGY NEWS, INTERNAL MEDICINE NEWS, FAMILY PRACTICE NEWS 10,000 South Dakota Academy of Physician Assistants DIABETIC MANAGEMENT,500 Tennessee Academy of Physician Assistants FALLFEST 015-RENAL DISEASE,500 Texas A&M University System Health Science Center Coastal Be 11TH ANNUAL DIABETES CONFERENCE 10,000 The Boston Home CARING FOR THE PATIENT WITH ADVANCED MULTIPLE SCLEROSIS 10,000 The Endocrine Society UPDATE IN BASAL INSULINS: YOUR QUESTIONS ANSWERED 19,040 The Endocrine Society 015 CLINICAL ENDOCRINOLOGY UPDATE 5,000 The Endocrine Society 015 CLINICAL ENDOCRINOLOGY UPDATE 5,000 Amount is the amount that the Company funded during Q, 015 identified above based upon an agreement. Recipients are

7 1 st Jul th Sep 015 Amount The France Foundation MS CLINICAL DIALOGS: A PEER DISCUSSION ON OPTIMAL TREATMENT (PHASE ) 76,547 The France Foundation National Society of Genetic Counselors A MULTI-DISCIPLINARY APPROACH TO LIMB-GIRDLE MUSCLE WEAKNESS DYSTROPHY AND RELATED CONDITIONS MANAGEMENT 40,794 The Medical College of Wisconsin, Inc. INTERACTIVE UPDATES IN USE OF STEM CELL MOBILIZATION FOR THE TREATMENT OF BLOOD RELATED CANCERS Carden Jennings Publishing Co., Ltd. 10,000 Ultimate Medical Academy, LLC dba Global Education Group Integritas Communications, LLC IMPROVING OUTCOMES IN RHEUMATOID ARTHRITIS: TREATING TO TARGET, IL-6- DIRECTED THERAPIES, AND EVOLVING MANAGEMENT ALGORITHMS 16,588 UMA MLG, LLC THE CHANGING LANDSCAPE OF DYSLIPIDEMIA TREATMENT 198,900 UMA MLG, LLC A -DIMENSIONAL VIEW INTO THE ROLE OF GLP1 IN TYPE- DIABETES: EXPLORING EVIDENCE-BASED GUIDELINES AS PATIENT-CENTERED THERAPY 0,000 University of California, San Diego Behavioral Diabetes Institute PROMOTING BEHAVIOR CHANGE IN DIABETES: A SKILL BUILDING PROGRAM FOR HEALTH CARE PROFESSIONALS A 50,000 University of Cincinnati Global Academy for Medical Education, LLC THE KNEE COURSE ,500 University of Virginia Renal Physicians Association RENAL PHYSICIANS ASSOCIATION 015 ADVANCED PRACTITIONER CONFERENCE 1,500 Amount is the amount that the Company funded during Q, 015 identified above based upon an agreement. Recipients are